Accepted abstracts are to be considered for oral or poster presentation.
Abstract submission deadline: March 22nd, 2025.
Abstract acceptance notification: March 29th, 2025.
Abstracts should be submitted electronically via e-mail on: abstracts@isco-eg.org
For more details, kindly visit: isco-eg.org
ISCO 2024 Abstract Winners:
Mohamed Ahmed Mansour
Abstract Title
Management and Outcome of Ewing Sarcoma in Pediatric Patients: A Single-Centre Experience.
Taha Abd-ElSalam
Abstract Title
Primed for death: Prognostic Role of BH3--Only Proteins in Breast Cancer Therapy: A Systematic and Meta-Analysis Review.
Haytham Abdelkader
Abstract Title
A Retrospective Clinicopathological Analysis for Cases of Double Primary Malignancies.
Nahla Ali
Abstract Title
Survival Analysis of Cutaneous Malignant Melanoma in the Pediatric Age Group: a SEER Based Study.
Nour ElHuda Hassan
Abstract Title
The Added Values of Contrast Enhanced Digital Mammography (CEDM) In the Evaluation of Indeterminate Breast Lesions.
ISCO 2023 Abstract Winners:
Ahmed Soliman
Abstract Title
Concurrent Chemoradiotherapy versus Neoadjuvant Chemotherapy Followed by Radical Hysterectomy for FIGO stage IIB Cervical Cancer Patients: A Systematic Review and Meta-analysis.
Ola Abou Elsoud
Abstract Title
The prolonged effect of Nivolumab as a second-line option in non-small-cell lung cancer patients after treatment discontinuation.
Dina Mohyeldeen
Abstract Title
Proton Pump Inhibitors Reduce Survival Outcomes in Patients Treated with Capecitabine: Meta-analysis.